| Mrs Shari Marie Jordan, CRNA | |
|
800 Rose St, Lexington, KY 40536-1439 | |
| (859) 323-5956 | |
| (859) 323-1080 |
| Full Name | Mrs Shari Marie Jordan |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 15 Years |
| Location | 800 Rose St, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053619577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 3016568 (Kentucky) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | 209008109 (Illinois) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Medical Center | Peoria, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Anesthesiologists Sc | 6305744129 | 118 |
News Archive
Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.
Kaiser Health News staff writer Mary Agnes Carey talks with Jackie Judd of the Kaiser Family Foundation about the impact an insurance industry report could have on this week's much anticipated health overhaul action.
Esophageal carcinoma (EC) is one of the major malignant diseases worldwide. Surgery alone cannot obtain satisfactory effects in patients with EC. Neoadjuvant chemoradiotherapy has been a hotspot for EC treatment research. Several related randomized controlled trials (RCTs) have been published, but opinions vary among clinicians as to the therapeutic effect of the new method.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.
› Verified 3 days ago
| Entity Name | Northwestern Medical Faculty Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346235314 PECOS PAC ID: 4587576814 Enrollment ID: O20031105000541 |
News Archive
Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.
Kaiser Health News staff writer Mary Agnes Carey talks with Jackie Judd of the Kaiser Family Foundation about the impact an insurance industry report could have on this week's much anticipated health overhaul action.
Esophageal carcinoma (EC) is one of the major malignant diseases worldwide. Surgery alone cannot obtain satisfactory effects in patients with EC. Neoadjuvant chemoradiotherapy has been a hotspot for EC treatment research. Several related randomized controlled trials (RCTs) have been published, but opinions vary among clinicians as to the therapeutic effect of the new method.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.
› Verified 3 days ago
| Entity Name | Windy City Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932248622 PECOS PAC ID: 9234033572 Enrollment ID: O20031120000022 |
News Archive
Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.
Kaiser Health News staff writer Mary Agnes Carey talks with Jackie Judd of the Kaiser Family Foundation about the impact an insurance industry report could have on this week's much anticipated health overhaul action.
Esophageal carcinoma (EC) is one of the major malignant diseases worldwide. Surgery alone cannot obtain satisfactory effects in patients with EC. Neoadjuvant chemoradiotherapy has been a hotspot for EC treatment research. Several related randomized controlled trials (RCTs) have been published, but opinions vary among clinicians as to the therapeutic effect of the new method.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.
› Verified 3 days ago
| Entity Name | Associated Anesthesiologists Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558306480 PECOS PAC ID: 6305744129 Enrollment ID: O20031230000544 |
News Archive
Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.
Kaiser Health News staff writer Mary Agnes Carey talks with Jackie Judd of the Kaiser Family Foundation about the impact an insurance industry report could have on this week's much anticipated health overhaul action.
Esophageal carcinoma (EC) is one of the major malignant diseases worldwide. Surgery alone cannot obtain satisfactory effects in patients with EC. Neoadjuvant chemoradiotherapy has been a hotspot for EC treatment research. Several related randomized controlled trials (RCTs) have been published, but opinions vary among clinicians as to the therapeutic effect of the new method.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.
› Verified 3 days ago
| Entity Name | Midwest Anesthesia Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255380184 PECOS PAC ID: 6204737596 Enrollment ID: O20040120000034 |
News Archive
Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.
Kaiser Health News staff writer Mary Agnes Carey talks with Jackie Judd of the Kaiser Family Foundation about the impact an insurance industry report could have on this week's much anticipated health overhaul action.
Esophageal carcinoma (EC) is one of the major malignant diseases worldwide. Surgery alone cannot obtain satisfactory effects in patients with EC. Neoadjuvant chemoradiotherapy has been a hotspot for EC treatment research. Several related randomized controlled trials (RCTs) have been published, but opinions vary among clinicians as to the therapeutic effect of the new method.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.
› Verified 3 days ago
| Entity Name | Allied Anesthesia Associates P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750330742 PECOS PAC ID: 0042118069 Enrollment ID: O20040203000134 |
News Archive
Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.
Kaiser Health News staff writer Mary Agnes Carey talks with Jackie Judd of the Kaiser Family Foundation about the impact an insurance industry report could have on this week's much anticipated health overhaul action.
Esophageal carcinoma (EC) is one of the major malignant diseases worldwide. Surgery alone cannot obtain satisfactory effects in patients with EC. Neoadjuvant chemoradiotherapy has been a hotspot for EC treatment research. Several related randomized controlled trials (RCTs) have been published, but opinions vary among clinicians as to the therapeutic effect of the new method.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.
› Verified 3 days ago
| Entity Name | American Anesthesiology Associates Of Illinois, S.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962512335 PECOS PAC ID: 3971498924 Enrollment ID: O20040218000526 |
News Archive
Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.
Kaiser Health News staff writer Mary Agnes Carey talks with Jackie Judd of the Kaiser Family Foundation about the impact an insurance industry report could have on this week's much anticipated health overhaul action.
Esophageal carcinoma (EC) is one of the major malignant diseases worldwide. Surgery alone cannot obtain satisfactory effects in patients with EC. Neoadjuvant chemoradiotherapy has been a hotspot for EC treatment research. Several related randomized controlled trials (RCTs) have been published, but opinions vary among clinicians as to the therapeutic effect of the new method.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.
› Verified 3 days ago
| Entity Name | North American Partners In Anesthesia Illinois Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699032524 PECOS PAC ID: 1052576519 Enrollment ID: O20120706000534 |
News Archive
Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.
Kaiser Health News staff writer Mary Agnes Carey talks with Jackie Judd of the Kaiser Family Foundation about the impact an insurance industry report could have on this week's much anticipated health overhaul action.
Esophageal carcinoma (EC) is one of the major malignant diseases worldwide. Surgery alone cannot obtain satisfactory effects in patients with EC. Neoadjuvant chemoradiotherapy has been a hotspot for EC treatment research. Several related randomized controlled trials (RCTs) have been published, but opinions vary among clinicians as to the therapeutic effect of the new method.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.
› Verified 3 days ago
| Entity Name | New Lenox Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093204778 PECOS PAC ID: 5991059214 Enrollment ID: O20181126001092 |
News Archive
Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.
Kaiser Health News staff writer Mary Agnes Carey talks with Jackie Judd of the Kaiser Family Foundation about the impact an insurance industry report could have on this week's much anticipated health overhaul action.
Esophageal carcinoma (EC) is one of the major malignant diseases worldwide. Surgery alone cannot obtain satisfactory effects in patients with EC. Neoadjuvant chemoradiotherapy has been a hotspot for EC treatment research. Several related randomized controlled trials (RCTs) have been published, but opinions vary among clinicians as to the therapeutic effect of the new method.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.
› Verified 3 days ago
| Entity Name | Novus Illinois Service Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295491744 PECOS PAC ID: 6901293786 Enrollment ID: O20220426000454 |
News Archive
Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.
Kaiser Health News staff writer Mary Agnes Carey talks with Jackie Judd of the Kaiser Family Foundation about the impact an insurance industry report could have on this week's much anticipated health overhaul action.
Esophageal carcinoma (EC) is one of the major malignant diseases worldwide. Surgery alone cannot obtain satisfactory effects in patients with EC. Neoadjuvant chemoradiotherapy has been a hotspot for EC treatment research. Several related randomized controlled trials (RCTs) have been published, but opinions vary among clinicians as to the therapeutic effect of the new method.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Shari Marie Jordan, CRNA 1200 Maple Rd, Joliet, IL 60432-1439 Ph: (815) 740-7910 | Mrs Shari Marie Jordan, CRNA 800 Rose St, Lexington, KY 40536-1439 Ph: (859) 323-5956 |
News Archive
Royal Philips a globally leading heath technology company, has announced that Lumify, a smart device ultrasound solution for use at the point of care, is available in the UK. Philips' new ultrasound digital health device connects off-the-shelf compatible smart devices, a mobile application, advanced ultrasound transducer technology, integrated IT and support services to help healthcare providers improve patient care while potentially reducing ultrasound associated costs.
Kaiser Health News staff writer Mary Agnes Carey talks with Jackie Judd of the Kaiser Family Foundation about the impact an insurance industry report could have on this week's much anticipated health overhaul action.
Esophageal carcinoma (EC) is one of the major malignant diseases worldwide. Surgery alone cannot obtain satisfactory effects in patients with EC. Neoadjuvant chemoradiotherapy has been a hotspot for EC treatment research. Several related randomized controlled trials (RCTs) have been published, but opinions vary among clinicians as to the therapeutic effect of the new method.
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.
› Verified 3 days ago
Keesha Ovee Watts, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 859-323-5956 Fax: 859-323-1080 | |
Robert Jason Crafton, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Department Of Anesthesiology, Lexington, KY 40536 Phone: 859-323-5956 Fax: 859-218-1080 | |
Kathleen Whitehouse, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 150 N Eagle Creek Dr, Lexington, KY 40509 Phone: 859-967-5000 | |
Richi C Gambrel, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 800 Rose Street, Lexington, KY 40536 Phone: 859-323-5000 | |
Mrs. Cynthia Napier, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: One Saint Joseph Drive, Lexington, KY 40504 Phone: 859-313-1000 | |
Mr. John Stepan Pototsky, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Rose St, Lexington, KY 40536 Phone: 859-323-5956 Fax: 859-323-1080 | |
Ms. Cathleen D. Bentley, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 150 N Eagle Creek Dr, Lexington, KY 40509 Phone: 859-967-5000 |